“To be able to do point of care testing is so valuable,” says Dr. Bardi. “If I see someone who has inflammatory arthritis, I can start treatment with them and then I can bring them back three months later after I’ve given them a drug and see what’s changed. When I can show them their old images and their new images and they can see the difference, it really helps with patient adherence.”

1. Canadian Association of Psoriasis Patients. Psoriasis – Comorbidities. Available at: https://www.canadianpsoriasis.ca/en/psoriasis/living-with-psoriasis/comorbidities . Accessed on April 24, 2024.


About Clarius Mobile Health 
Clarius is on a mission to make accurate, easy-to-use, and affordable ultrasound tools available to all medical professionals in every specialty. With decades of experience in medical imaging, the team knows that great ultrasound imaging improves confidence and patient care. Today, AI-powered Clarius handheld wireless ultrasound scanners connect to iOS and Android devices, delivering high-resolution ultrasound images traditionally only available with bulkier, high-end systems at a fraction of the cost. Almost 4 million high-definition scans have been performed using Clarius wireless handheld scanners. Clarius scanners are available in over 90 countries worldwide. Learn more at www.clarius.com. 

About Novartis 
Novartis is a focused innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Reimagine medicine with us:  

In Canada, Novartis Pharmaceuticals Canada Inc. employs approximately 600 people to serve the evolving needs of patients and the healthcare system and invests over $30 million in R&D yearly in the country.

Back to HCB News

Business Affairs Homepage